Furthermore, in all four human cancer types analyzed, signals from AP-TRAIL binding could be essentially completely competed away with 10-fold excess of untagged rhTRAIL suggesting that the DR signal detected by AP-TRAIL is indeed ligand specific. This evidence concerns the gene TNFSF10 and cancer.